A recent report from Ernst & Young (EY) showed that 65% of healthcare organizations have had a positive return on health equity efforts and 83% have seen improved health outcomes. The report, based on a survey of 500 health equity leaders, found that most organizations believe prioritization and financial investment in health equity will increase….
New findings suggest that Artificial intelligence (AI) could help in understanding the origins and development of Parkinson’s disease. Preliminary results from a study using the AI software programme, NetraAI, identified markers associated with Parkinson’s disease, particularly related to immune system responses. This research has the potential to improve clinical trials and accelerate the development of…
DarioHealth reported a significant decrease in revenue for Q4 2023 compared to the previous year, with a net loss also increasing. The company attributed the decrease in revenue to lower consumer and strategic partner channels. Despite this, DarioHealth’s CEO expressed optimism about the company’s pivot to a new business model, which includes the recent acquisition…
Céline Gounder, Andy Miller, and Arielle Zionts, all senior fellows and editors at KFF Health News, discussed various health-related topics on different platforms in March. Gounder talked about the 2024 U.S. measles outbreak on WAMU’s “A1” show, Miller discussed Medicaid expansion on The Atlanta Journal-Constitution’s “Politically Georgia,” and Zionts focused on Montana’s abortion access on…
Adagrasib, a RAS GTPase inhibitor, has shown promise in improving progression-free survival and overall response rate in adults with KRASG12C-mutated non-small cell lung cancer, according to results from a phase 3 trial. The drug received accelerated FDA approval for use in previously treated patients. The study found that adagrasib was superior to standard chemotherapy, meeting…
A new analysis found that people in Republican-voting states were more likely to report adverse events after receiving a Covid-19 vaccination compared to those in Democratic-leaning states. The study, published in JAMA Network Open, found that a 10% increase in Republican votes in the last presidential election was associated with increased reporting of adverse events….
Ann Robinson reviews the latest research on the use of aspirin in treating metabolic dysfunction-associated steatotic liver disease. A preliminary study found that taking a low dose of aspirin for six months reduced hepatic fat quantity significantly. However, further research with a larger sample size is needed. In another study, text message and patient portal…
Researchers from Lund University have identified molecular signatures associated with sepsis that could improve diagnosis and prognosis. This research presented at ECCMID 2024 in Barcelona aims to target specific therapies at patients who would benefit most. Sepsis is a life-threatening condition triggered by infection, with no singular diagnostic test available. The study analyzed plasma samples…
Blood in insects, called hemolymph, can clot quickly outside the body, but how this happens has remained a mystery. Researchers have discovered that caterpillars of the Carolina sphinx moth, tobacco hornworms, can seal wounds in a minute by transforming their hemolymph from a water-like substance to a viscoelastic fluid. This change allows the hemolymph to…
For most people with multiple sclerosis (MS), alcohol can be consumed in moderation. The U.S. Dietary Guidelines recommend no more than one drink a day for women and two for men. Regularly drinking alcohol can worsen neurological damage and function for MS patients, but an occasional glass or beer is unlikely to cause significant issues….
